HCA Holdings Inc. (NYSE:HCA) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Friday.

According to Zacks, “HCA Inc. is a non-governmental hospital in the U.S. providing health care and related services. The Company operates a network of acute care hospitals, outpatient facilities, clinics and other patient care delivery settings. The Company also owns and manages freestanding surgery centers, diagnostic and imaging centers, radiation and oncology therapy centers, rehabilitation and physical therapy centers, and various other facilities. HCA Inc. is headquartered in Nashville, Tennessee. “

HCA has been the subject of a number of other research reports. Jefferies Group restated a “buy” rating on shares of HCA Holdings in a research note on Tuesday, September 6th. KeyCorp upgraded HCA Holdings from a “sector weight” rating to an “overweight” rating and set a $94.00 target price for the company in a research report on Thursday, October 13th. Royal Bank Of Canada lifted their target price on HCA Holdings from $88.00 to $95.00 and gave the stock an “outperform” rating in a research report on Friday, October 28th. JPMorgan Chase & Co. lowered HCA Holdings from an “overweight” rating to a “neutral” rating and set a $85.00 target price for the company. in a research report on Friday, July 29th. Finally, Wolfe Research began coverage on HCA Holdings in a research report on Tuesday, October 25th. They issued an “outperform” rating for the company. Nine equities research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of $87.43.

Analyst Recommendations for HCA Holdings (NYSE:HCA)

Shares of HCA Holdings (NYSE:HCA) opened at 71.94 on Friday. HCA Holdings has a 1-year low of $60.07 and a 1-year high of $83.69. The stock’s 50 day moving average price is $76.96 and its 200 day moving average price is $77.41. The stock has a market cap of $26.95 billion, a PE ratio of 11.39 and a beta of 0.79.

HCA Holdings (NYSE:HCA) last issued its quarterly earnings data on Thursday, October 27th. The company reported $1.61 earnings per share for the quarter, beating analysts’ consensus estimates of $1.42 by $0.19. HCA Holdings had a negative return on equity of 43.65% and a net margin of 6.10%. The firm earned $10.27 billion during the quarter, compared to analyst estimates of $10.41 billion. During the same quarter last year, the firm earned $1.17 EPS. HCA Holdings’s quarterly revenue was up 4.2% on a year-over-year basis. On average, equities research analysts anticipate that HCA Holdings will post $6.71 EPS for the current fiscal year.

In other news, insider Michael S. Cuffe sold 2,150 shares of HCA Holdings stock in a transaction on Friday, October 28th. The stock was sold at an average price of $79.41, for a total transaction of $170,731.50. The sale was disclosed in a filing with the SEC, which is available at this link. Also, SVP Sandra L. Morgan sold 18,556 shares of HCA Holdings stock in a transaction on Tuesday, November 8th. The shares were sold at an average price of $76.84, for a total value of $1,425,843.04. Following the transaction, the senior vice president now owns 7,968 shares in the company, valued at approximately $612,261.12. The disclosure for this sale can be found here. Insiders own 3.10% of the company’s stock.

Several hedge funds and other institutional investors have recently modified their holdings of HCA. Longview Partners Guernsey LTD increased its position in shares of HCA Holdings by 1.5% in the third quarter. Longview Partners Guernsey LTD now owns 9,139,019 shares of the company’s stock worth $691,184,000 after buying an additional 132,360 shares in the last quarter. Magellan Asset Management Ltd acquired a new position in shares of HCA Holdings during the second quarter worth $489,097,000. Harris Associates L P increased its position in shares of HCA Holdings by 651.7% in the third quarter. Harris Associates L P now owns 5,086,931 shares of the company’s stock worth $384,724,000 after buying an additional 4,410,239 shares in the last quarter. JPMorgan Chase & Co. increased its position in shares of HCA Holdings by 3.4% in the second quarter. JPMorgan Chase & Co. now owns 4,441,413 shares of the company’s stock worth $342,033,000 after buying an additional 144,396 shares in the last quarter. Finally, BlackRock Fund Advisors increased its position in shares of HCA Holdings by 0.5% in the second quarter. BlackRock Fund Advisors now owns 4,024,847 shares of the company’s stock worth $309,953,000 after buying an additional 20,343 shares in the last quarter. Institutional investors and hedge funds own 71.43% of the company’s stock.

About HCA Holdings

HCA Holdings, Inc is a healthcare services company. The Company’s segment is operating hospitals and related healthcare entities. The Company operates approximately 168 hospitals, consisting of 164 general, acute care hospitals; three psychiatric hospitals, and one rehabilitation hospital. In addition, the Company operates approximately 116 freestanding surgery centers.

5 Day Chart for NYSE:HCA

Receive News & Stock Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related stocks with our FREE daily email newsletter.